Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging

European Journal of Radiology

Volumn 48, Issue 3, 2003, Pages 244-251

  Preul, Christoph ^a,b   Kühn, Bernd ^a   Lang, Erhard W ^a   Mehdorn, H Maximilian ^a   Heller, Martin ^a   Link, Johann ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

Author keywords

Cerebral blood volume; Echo planar imaging; Malignant glioma; Perfusion measurement

Indexed keywords

BIOPSY; BLOOD; HISTOLOGY; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; NEUROLOGY;

REGIONAL CEREBRAL BLOOD VOLUME (RCBV); STEREOTACTIC BIOPSY;

TUMORS;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; BRAIN BLOOD VOLUME; BRAIN SURGERY; BRAIN TUMOR; CANCER GRADING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHO PLANAR MAGNETIC RESONANCE PERFUSION IMAGING; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; MALE; MATHEMATICAL COMPUTING; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STEREOTAXIC SURGERY; STEREOTAXIS; TUMOR CLASSIFICATION;

EID: 0344494541     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(03)00050-0     Document Type: Article

References (22)

1. Alavi J.B., Alavi A., Chawluk J., et al. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer. 62:1988;1074-1078.
2. Di Chiro G., DeLaPaz R.L., Brooks R.A., et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology. 32:1982;1323-1329.
3. Di Chiro G., Oldfield E., Wright D.C., et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. Am. J. Roentgenol. 150:1988;189-197.
4. Aronen H.J., Glass J., Pardo F.S., et al. Echo-planar MR cerebral blood volume mapping of gliomas. Acta Radiol. 36:1995;520-528.
5. Knopp E.A., Cha S., Johnson G., et al. Kricheff II: glial neoplasms. Dynamic contrast-enhanced T2*-weighted MR imaging. Radiology. 211:1999;791-798.
6. Maeda M., Itoh S., Kimura H., et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology. 189:1993;233-238.
7. Siegal T., Rubinstein R., Tzuk-Shina T., Gomori J.M. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J. Neurosurg. 86:1997;22-27.
8. Edelman R.R., Mattle H.P., Atkinson D.J., et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5T. Radiology. 176:1990;211-220.
9. Rosen B.R., Belliveau J.W., Chien D. Perfusion imaging by nuclear magnetic resonance. Magn. Reson. Q. 5:1989;263-281.
10. Rosen B.R., Belliveau J.W., Vevea J.M., Brady T.J. Perfusion imaging with NMR contrast agents. Magn. Reson. Med. 14:1990;249-265.
11. Gullberg G.T., Wehrli F.W., Shimakawa A., Simons M.A. MR vascular imaging with a fast gradient refocusing pulse sequence and reformatted images from transaxial sections. Radiology. 165:1987;241-246.
12. Fisel C.R., Ackerman J.L., Buxton R.B., et al. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn. Reson. Med. 17:1991;336-347.
13. Villringer A., Rosen B.R., Belliveau J.W., et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn. Reson. Med. 6:1988;164-174.
14. Axel L. Cerebral blood flow determined by rapid-sequence computed tomography. Radiology. 137:1980;679-686.
15. Meier P., Zierler K.L. On the theory of the indicator-dilution method for measurement of blood flow and volume. J. Appl. Physiol. 6:1954;731-744.
16. Zierler K.L. Theoretical basis of indicator dilution methods for measuring flow and volume. Circ. Res. 10:1962;393-407.
17. Lee S.J., Kim J.H., Kim Y.M., et al. Perfusion MR imaging in gliomas: comparison with histologic tumor grade. Korean J. Radiol. 2:(1):2001;1-7.
18. Hartmann M., Heiland S., Sartor K. Funktionelle MR - verfahren in der diagnostik intraaxialer hirntumoren: perfusions- und diffusions-bildgebung. Fortschr. Röntgenstr. 174:2002;955-964.
19. Vajkoczy P., Menger M.D. Vascular microenvironment in gliomas. J. Neurooncol. 50:(1-2):2000;99-108.
20. Shin J.H., Lee H.K., Kwun B.D., et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Am. J. Roentgenol. 179:(3):2002;783-789.
21. Aronen H.J., Gazit I.E., Louis D.N., et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology. 191:1994;41-51.
22. Rosen B.R., Belliveau J.W., Buchbinder B.R., et al. Contrast agents and cerebral hemodynamics. Magn. Reson. Med. 19:1991;285-292.